Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: J Mol Cell Cardiol. 2014 Feb 20;72:1–8. doi: 10.1016/j.yjmcc.2014.02.008

Table 1. Clinical characteristics.

A. Patients with heart failure

Sex Age (y) Cardiomyopathy Medications
F 49 Non ischemic, idiopathic Diuretic, Inotropes, Digoxin
M 65 Ischemic Diuretic, ACE inhibitor/ARB, β-blockers,
Inotropes, Digoxin, Statin, Insulin
M 63 Ischemic Diuretic, ACE inhibitor/ARB, β-blockers, Statin
M 49 Non ischemic, idiopathic Diuretics, Inotropes
M 39 Non ischemic, idiopathic Inotropes, Statin
M 64 Ischemic Diuretics, β-blockers, Inotropes, digoxin
M 61 Ischemic Diuretic, ACE inhibitor/ARB, Inotropes, Statin -
F 23 Non ischemic, postpartum Diuretic, ACE inhibitor/ARB, β-blockers,
Inotropes
M 20 Non ischemic, idiopathic Diuretic, ACE inhibitor/ARB, Digoxin
M 53 Ischemic Diuretic, β-blockers, Inotropes, Digoxin

B. Donors with non-failing hearts

Sex Age (y) Cause of death

F 31 Stroke
M 59 Stroke
F 18 Head Trauma
F 38 Stroke
M 28 Head Trauma
M 33 Head Trauma